中国医药科学2024,Vol.14Issue(5) :107-110.DOI:10.20116/j.issn2095-0616.2024.05.24

基于"补肾调肝"法治疗帕金森病的思路

The idea of treating Parkinson's disease based on the"invigorating the kidney and regulating the liver"method

李果 梁美丹 高云水 马守文 朱松柏 左龙 杨毅 卢梁 吴鹏
中国医药科学2024,Vol.14Issue(5) :107-110.DOI:10.20116/j.issn2095-0616.2024.05.24

基于"补肾调肝"法治疗帕金森病的思路

The idea of treating Parkinson's disease based on the"invigorating the kidney and regulating the liver"method

李果 1梁美丹 2高云水 1马守文 1朱松柏 1左龙 1杨毅 1卢梁 1吴鹏3
扫码查看

作者信息

  • 1. 湖南中医药大学附属岳阳市中医医院急诊科,湖南岳阳 414000
  • 2. 广西中医药大学研究生院,广西南宁 530000
  • 3. 广西中医药大学第一附属医院脑病科,广西南宁 530023
  • 折叠

摘要

伴随人口老龄化加剧,帕金森病(PD)的致病率呈现出被推波助澜之势,历代医家及学者对其均有独到的见解,肝肾阴虚作为其中秉要执本的病因病机,被众人所推崇.众多临床实践和基础研究证明,"补肾调肝"法作为治疗PD常规治疗法则,运用"补肾调肝"法治疗PD常可以达到药到病除之功,被广泛应用于临床实践.通过查阅与PD相关的实验与临床研究文献,本文探讨"补肾调肝"法在治疗PD中的应用,并结合临床医案进行剖析,以期为今后的辨证论治与临床用药提供相应的思路和借鉴.

Abstract

With the increasing aging population,the morbidity of Parkinson's disease(PD)has shown a trend of increasing momentum.Throughout history,doctors and scholars have unique insights into it.Deficiency of liver-yin and kidney-yin,as one of the fundamental causes and pathogenesis,is highly regarded by everyone.Numerous clinical practices and basic research have proven that the"invigorating the kidney and regulating the liver"method,as a routine treatment rule for PD,can often achieve the effect of treating the disease radically with medicine in the treatment of PD and is widely used in clinical practice.By reviewing experimental and clinical literature related to PD,this article attempts to explore the application of the"invigorating the kidney and regulating the liver"method in the treatment of PD and analyze it based on clinical medical records,to provide corresponding ideas and references for future syndrome differentiation and treatment and clinical medication.

关键词

帕金森病/"补肾调肝"法/文献研究/临床医案

Key words

Parkinson's disease/The"invigorating the kidney and regulating the liver"method/Literature research/Clinical medical records

引用本文复制引用

基金项目

广西自然科学基金(2019JJA140254)

出版年

2024
中国医药科学
海峡两岸医药卫生交流协会 二十一世纪联合创新(北京)医药科学研究院

中国医药科学

影响因子:1.083
ISSN:2095-0616
参考文献量15
段落导航相关论文